CervoMed Inc. (TRADEGATE:DP8) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Sol J. Barer Other companies: Teva Pharmaceutical Industries Limited (Director · Since at least Jan 1, 2018); NexImmune, Inc. (Director · Feb 11, 2021 – Jul 5, 2023 · Past); Avalo Therapeutics, Inc. (Director · Feb 3, 2020 – Jun 15, 2021 · Past); PDS Biotechnology Corporation (Director · Sep 30, 2015 – Mar 15, 2019 · Past); Aevi Genomic Medicine LLC (Director · Jun 30, 2012 – Feb 3, 2020 · Past); InspireMD Inc. (Director · Jul 11, 2011 – Dec 7, 2016 · Past); Aegerion Pharmaceuticals Inc (Director · May 1, 2011 – Nov 29, 2016 · Past); Amicus Therapeutics Inc (Director · Jan 6, 2009 – Jun 9, 2016 · Past); Celgene Corporation (Director · Dec 31, 2005 – Jan 13, 2011 · Past) | Director · Nov 1, 2013 – Jul 24, 2014 · Past |
| Isaac Blech Other companies: X4 Pharmaceuticals, Inc. (Director · Mar 13, 2019 – Mar 13, 2019 · Past); Aridis Pharmaceuticals Inc. (Director · Aug 13, 2018 – Aug 13, 2018 · Past); InspireMD Inc. (Director · Jan 22, 2016 – Dec 7, 2016 · Past); Avalo Therapeutics, Inc. (Director · Oct 14, 2015 – Dec 31, 2018 · Past); PDS Biotechnology Corporation (Director · Sep 30, 2015 – Mar 15, 2019 · Past); SpendSmart Networks Inc (Director · Aug 1, 2014 – Jul 19, 2016 · Past); Aevi Genomic Medicine LLC (Director · Nov 11, 2013 – Apr 15, 2016 · Past) | Director · Jul 24, 2014 – Aug 31, 2016 · Past |
| Phillip Donenberg Other companies: Sensei Biotherapeutics, Inc. (Chair of the Audit Committee · Since at least Feb 13, 2026); Taysha Gene Therapies, Inc. (Director · Since at least Sep 23, 2020); Tectonic Therapeutic, Inc. (Director · Since at least Jun 20, 2018); Depomed Inc (SVP and CFO · Jul 16, 2018 – Jul 16, 2018 · Past); AveXis Inc (Chief Financial Officer · Oct 19, 2017 – May 15, 2018 · Past); ANI Pharmaceuticals, Inc. (Sr VP of Finance, CFO, Secy · Mar 16, 2006 – Jan 25, 2012 · Past) | Director · May 27, 2014 – Jul 24, 2014 · Past |
| Robert R. Ruffolo Other companies: LB Pharmaceuticals Inc (Independent Director · Since at least Sep 10, 2025); Elicio Therapeutics, Inc. (Director · Since at least Jun 1, 2023); Sigilon Therapeutics Inc (Director · Dec 3, 2020 – Aug 11, 2023 · Past); Aridis Pharmaceuticals Inc. (Director · Aug 13, 2018 – Dec 5, 2022 · Past) | Director · Jun 29, 2017 – Jun 14, 2018 · Past |
| Alan Levin Other companies: BioCryst Pharmaceuticals, Inc. (Director · Since at least Feb 27, 2020); Aceto Corporation (Director · Dec 5, 2013 – Oct 1, 2019 · Past); Pfizer, Inc. (Senior Vice President · Dec 30, 2005 – Sep 14, 2007 · Past) | Director · Jan 8, 2016 – Jul 1, 2021 · Past |
| Eric Francois Other companies: 60 Degrees Pharmaceuticals, Inc. (Director · Since at least May 13, 2026); CERo Therapeutics Holdings, Inc. (Director · Since at least Feb 13, 2026); Scynexis, Inc. (Chief Financial Officer · Nov 1, 2015 – Jan 29, 2021 · Past) | Director · Jun 25, 2021 – Jul 1, 2021 · Past |
| Sylvie Grégoire Other companies: Revvity, Inc. (Director · Feb 6, 2015 – May 15, 2023 · Past); Idm Pharma Inc (Director · Jun 14, 2006 – Jun 14, 2007 · Past); Cubist Pharmaceuticals Inc (Director · Jun 9, 2006 – Jun 10, 2010 · Past) | Co-Founder · Since at least Aug 16, 2023 |
| Jeffrey V Poulton Other companies: Alnylam Pharmaceuticals, Inc. (EVP, Chief Financial Officer · Since at least Aug 13, 2019); Q32 Bio Inc. (Director · Jul 21, 2020 – Jun 14, 2023 · Past) | Director · Since at least Aug 16, 2023 |
| John Alam Other companies: Pathfinder Cell Therapy Inc (Director · Sep 2, 2011 – Sep 2, 2011 · Past); Vertex Pharmaceuticals Incorporated (EVP, Med. Dev. Group & CMO · Dec 20, 2005 – Oct 1, 2008 · Past) | Co-Founder and Chief Executive Officer · Since at least Aug 16, 2023 |
| Stephen M. Simes Other companies: CytoDyn Inc. (Director · Since at least Oct 13, 2022); ANI Pharmaceuticals, Inc. (Vice Chairman, President & CEO, Director · Dec 14, 2007 – Jan 25, 2012 · Past) | Chief Executive Officer, Director · Mar 5, 2014 – Jul 24, 2014 · Past |
| Timothy Boris Other companies: Vogenx Inc (Director · Since at least Aug 11, 2026); SpendSmart Networks Inc (General Counsel · Jan 20, 2015 – Jan 20, 2015 · Past) | Director · Jun 9, 2014 – Jul 24, 2014 · Past |
| Frank Zavrl Other companies: Puma Biotechnology Inc (Director · Sep 8, 2015 – Jun 9, 2020 · Past) | Director · Since at least Aug 16, 2023 |
| Glenn Golenberg Other companies: Grill Concepts Inc (Director · Jun 21, 2006 – Jun 12, 2008 · Past) | Director · Apr 30, 2009 – Apr 30, 2009 · Past |
| Jane H. Hollingsworth Other companies: NuPathe Inc. (Chief Executive Officer, Director · Aug 5, 2010 – Mar 8, 2012 · Past) | Director · Since at least Sep 1, 2020 |
| Jeff Poulton Other companies: Alnylam Pharmaceuticals, Inc. (Chief Financial Officer · Since at least Nov 4, 2026) | Director · Since at least Nov 4, 2026 |
| Joshua Boger Other companies: Vertex Pharmaceuticals Incorporated (Director · Feb 2, 2006 – Jun 8, 2017 · Past) | Chair Of The Board · Since at least Feb 7, 2024 |
| Kelly Blackburn Other companies: aTyr Pharma, Inc. (VP, Clinical Affairs · May 6, 2015 – Mar 28, 2016 · Past) | Executive Vice President, Clinical Development · Since at least Aug 16, 2023 |
| Mark De Rosch Other companies: Aura Biosciences, Inc. (Chief Operating Officer · Oct 28, 2021 – Jan 19, 2023 · Past) | Executive Vice President, Regulatory and Government Affairs, and Program Management · Since at least May 1, 2025 |
| Matthew Winton Other companies: Inozyme Pharma Inc (COO · Since at least Apr 3, 2023) | Chief Commercial and Business Officer · Since at least Oct 6, 2025 |
| Rex Bright Other companies: VYNE Therapeutics Inc. (Director · Jul 19, 2021 – Jul 19, 2021 · Past) | Director · Feb 5, 2014 – Jul 24, 2014 · Past |
| William Karl Hornung Other companies: Hepion Pharmaceuticals, Inc. (Chief Financial Officer · Jun 23, 2014 – Jun 4, 2015 · Past) | Chief Financial Officer · Sep 21, 2018 – Jan 27, 2022 · Past |
| Ben Shealy | Sr VP Finance & Treasurer · Jan 8, 2016 – Jan 2, 2018 · Past |
| Christopher D Galloway | Chief Medical Officer · Oct 19, 2020 – Jan 27, 2022 · Past |
| Craig Abolin | VP of Research & Dev - Subsid. · Nov 18, 2013 – Jun 3, 2014 · Past |
| David G Kalergis | Chairman and CEO, Director · Jan 8, 2016 – Jan 2, 2020 · Past |
| David Quigley | Senior Partner · Since at least Oct 27, 2025 |
| David Randolph Jones | Chief Medical Officer · Jan 8, 2016 – Jan 8, 2016 · Past |
| Diana M Lanchoney | Director · Jun 25, 2021 – Jun 30, 2023 · Past |
| Jill Davidson | Director · Jul 26, 2023 – Sep 15, 2023 · Past |
| John Schneider | Director · Sep 13, 2012 – Sep 13, 2012 · Past |
| John William Tanner | Chief Financial Officer · Aug 16, 2023 – Jan 26, 2024 · Past |
| Marco Verwijs | Executive Vice President, Technical Operations · Since at least Mar 4, 2026 |
| Mark A Weinberg | Sr.V.P.- Clinical Development · Aug 4, 2014 – Aug 4, 2014 · Past |
| Mark T Giles | Director · Jan 8, 2016 – Jul 1, 2021 · Past |
| Marwan Sabbagh | Director · Since at least Aug 16, 2023 |
| Mike Dunleavy Sr | Director · Oct 15, 2009 – Oct 15, 2009 · Past |
| Nelson K Stacks | Director · Nov 18, 2013 – Jul 24, 2014 · Past |
| PJ Kelleher | Investor Relations · Since at least Dec 4, 2025 |
| Raven Jaeger | Chief Regulatory Officer · May 18, 2022 – Jun 7, 2022 · Past |
| Robert Joseph Cobuzzi Jr | Chief Operating Officer · Jan 7, 2020 – Feb 4, 2025 · Past |
| Robert W Adams | Director · Jan 8, 2016 – Jul 1, 2021 · Past |
| Thomas E Byrne | General Counsel · Jan 8, 2016 – Jan 7, 2020 · Past |
| William Elder | Chief Financial Officer and General Counsel · Since at least Sep 22, 2020 |
| Yael Schwartz | Exe. VP Preclinical Dev., Director · Nov 18, 2013 – Jul 24, 2014 · Past |